Association of HSV reactivation and pro-inflammatory cytokine levels with the severity of stomatitis after BEAM chemotherapy and autologous SCT

Supportive Care in Cancer

Volumn 19, Issue 8, 2011, Pages 1211-1216

  Rüping, Maria J G T ^a   Keulertz, Constance ^a   Vehreschild, Jörg J ^a   Lövenich, Harry ^b   Söhngen, Dietmar ^c   Wieland, Ulrike ^a   Cornely, Oliver A ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b St Jans Gasthuis Neurologie   (Netherlands)

^c Reha Zentrum Reichshof   (Germany)

Author keywords

Autologous stem cell transplantation; HSV stomatitis; Mucositis; Prophylaxis

Indexed keywords

CARMUSTINE; CYTARABINE; ETOPOSIDE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTERLEUKIN 1; MELPHALAN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIBODY TITER; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER RECURRENCE; CANCER STAGING; CELL CULTURE; CLINICAL ARTICLE; COMPOSITE LYMPHOMA; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG MEGADOSE; FEMALE; HERPES SIMPLEX VIRUS; HERPETIC STOMATITIS; HODGKIN DISEASE; HUMAN; INFLUENZA A; MALE; MORBIDITY; MUCOSA INFLAMMATION; NONHODGKIN LYMPHOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SALIVA ANALYSIS; SEROLOGY; VARICELLA ZOSTER VIRUS; VIRUS ISOLATION; VIRUS REACTIVATION;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARMUSTINE; CYTARABINE; CYTOKINES; FEMALE; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HODGKIN DISEASE; HUMANS; INFLAMMATION; INTERLEUKIN-1; LYMPHOMA, NON-HODGKIN; MALE; MELPHALAN; MIDDLE AGED; PODOPHYLLOTOXIN; SALIVA; SEVERITY OF ILLNESS INDEX; STATISTICS AS TOPIC; STEM CELL TRANSPLANTATION; STOMATITIS; TRANSPLANTATION, AUTOLOGOUS; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 80051577538     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-010-0940-8     Document Type: Article

References (30)

1. National Cancer Institute (2010) Oral Complications of Chemotherapy and Head/Neck Radiation. National Cancer Institute, Bethesda, MD, USA
2. Y Alvarado LA Bellm FJ Giles 2002 Oral mucositis: time for more studies Hematology 7 281 289 12850815 10.1080/1024533021000037216 1:CAS:528: DC%2BD38XovVCkt78%3D (Pubitemid 36007755)
3. M Attal F Huguet H Rubie JP Charlet D Schlaifer A Huynh G Laurent J Pris 1993 Prevention of regimen-related toxicities after bone marrow transplantation by pentoxifylline: a prospective, randomized trial Blood 82 732 736 8338943 1:STN:280:DyaK3szjtlSktQ%3D%3D (Pubitemid 23221650)
4. JA Bianco FR Appelbaum J Nemunaitis J Almgren F Andrews P Kettner A Shields JW Singer 1991 Phase I-II trial of pentoxifylline for the prevention of transplant-related toxicities following bone marrow transplantation Blood 78 1205 1211 1878587 1:STN:280:DyaK3Mzks1yhtQ%3D%3D
5. N Blijlevens M Schwenkglenks P Bacon A D'Addio H Einsele J Maertens D Niederwieser W Rabitsch A Roosaar T Ruutu H Schouten R Stone S Vokurka B Quinn S McCann 2008 Prospective oral mucositis audit: oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy - European Blood and Marrow Transplantation Mucositis Advisory Group J Clin Oncol 26 1519 1525 18268357 10.1200/JCO.2007.13.6028 1:CAS:528:DC%2BD1cXkslKqsLk%3D
6. Y Doi T Ninomiya J Hata K Yonemoto Y Tanizaki H Arima Y Liu M Rahman M Iida Y Kiyohara 2009 Seroprevalence of herpes simplex virus 1 and 2 in a population-based cohort in Japan J Epidemiol 19 56 62 19265271 10.2188/jea.JE20080061
7. JP Donnelly LA Bellm JB Epstein ST Sonis RP Symonds 2003 Antimicrobial therapy to prevent or treat oral mucositis Lancet Infect Dis 3 405 412 12837345 10.1016/S1473-3099(03)00668-6 (Pubitemid 36791117)
8. A Eigler F Loher S Endres 2001 34 Internist (Berl) 42 28 34 10.1007/s001080050721 1:STN:280:DC%2BD3M7ntFaisQ%3D%3D (Pubitemid 32221181)
9. J Eilers AM Berger MC Petersen 1988 Development, testing, and application of the oral assessment guide Oncol Nurs Forum 15 325 330 3287344 1:STN:280:DyaL1c3jsVSksQ%3D%3D
10. D Eisen J Essell ER Broun D Sigmund M DeVoe 2003 Clinical utility of oral valacyclovir compared with oral acyclovir for the prevention of herpes simplex virus mucositis following autologous bone marrow transplantation or stem cell rescue therapy Bone Marrow Transplant 31 51 55 12621507 10.1038/sj.bmt.1703817 1:CAS:528:DC%2BD3sXitVygurg%3D (Pubitemid 36181822)
11. JM Fall-Dickson ES Ramsay K Castro P Woltz C Sportes 2007 Oral mucositis-related oropharyngeal pain and correlative tumor necrosis factor-alpha expression in adult oncology patients undergoing hematopoietic stem cell transplantation Clin Ther 29 Suppl 2547 2561 18164921 10.1016/j.clinthera.2007. 12.004 1:CAS:528:DC%2BD1cXht12qt7w%3D (Pubitemid 350299459)
12. E Gluckman J Lotsberg A Devergie XM Zhao R Melo M Gomez-Morales MC Mazeron Y Perol 1983 Oral acyclovir prophylactic treatment of herpes simplex infection after bone marrow transplantation J Antimicrob Chemother 12 Suppl B 161 167 6313595 (Pubitemid 14228011)
13. IM Hann HG Prentice HA Blacklock MG Ross D Brigden AE Rosling C Burke DH Crawford W Brumfitt AV Hoffbrand 1983 Acyclovir prophylaxis against herpes virus infections in severely immunocompromised patients: randomised double blind trial Br Med J (Clin Res Ed) 287 384 388 10.1136/bmj.287.6389.384 1:STN:280:DyaL3s3lvVCgsw%3D%3D (Pubitemid 13026258)
14. MV Jacobs PJ Snijders AJ van den Brule TJ Helmerhorst CJ Meijer JM Walboomers 1997 A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings J Clin Microbiol 35 791 795 9041439 1:CAS:528:DyaK2sXhslWksLw%3D (Pubitemid 27083888)
15. Kramer MA, Uitenbroek DG, Ujcic-Voortman JK, Pfrommer C, Spaargaren J, Coutinho RA, Dukers-Muijrers NH (2008) Ethnic differences in HSV1 and HSV2 seroprevalence in Amsterdam, the Netherlands Euro Surveill 13
16. W Liedtke B Opalka CW Zimmermann E Lignitz 1993 Age distribution of latent herpes simplex virus 1 and varicella-zoster virus genome in human nervous tissue J Neurol Sci 116 6 11 8389816 10.1016/0022-510X(93)90082-A 1:STN:280:DyaK3s3os1Kguw%3D%3D (Pubitemid 23144787)
17. JL Liesveld CN Abboud JJ Ifthikharuddin JE Lancet LA Wedow J Oliva CG Stamm D Nichols 2002 Oral valacyclovir versus intravenous acyclovir in preventing herpes simplex virus infections in autologous stem cell transplant recipients Biol Blood Marrow Transplant 8 662 665 12523578 10.1053/bbmt.2002.v8. abbmt080662 1:CAS:528:DC%2BD3sXpsVKltg%3D%3D (Pubitemid 36097805)
18. RM Logan AM Stringer JM Bowen AS Yeoh RJ Gibson ST Sonis DM Keefe 2007 The role of pro-inflammatory cytokines in cancer treatment-induced alimentary tract mucositis: pathobiology, animal models and cytotoxic drugs Cancer Treat Rev 33 448 460 17507164 10.1016/j.ctrv.2007.03.001 1:CAS:528: DC%2BD2sXpvF2lsrY%3D (Pubitemid 47324227)
19. D Malvy B Halioua F Lancon A Rezvani S Bertrais B Chanzy M Daniloski K Ezzedine JE Malkin P Morand C De Labareyre S Hercberg A El Hasnaoui 2005 Epidemiology of genital herpes simplex virus infections in a community-based sample in France: results of the HERPIMAX study Sex Transm Dis 32 499 505 16041253 10.1097/01.olq.0000161188.82905.b7 (Pubitemid 41060391)
20. F Morfin K Bilger A Boucher A Thiebaut F Najioullah N Bleyzac N Raus S Bosshard M Aymard M Michallet D Thouvenot 2004 HSV excretion after bone marrow transplantation: a 4-year survey J Clin Virol 30 341 345 15163425 10.1016/j.jcv.2004.03.002 (Pubitemid 38649104)
21. PO Mulder P Schroder HG de Vries-Hospers S van der Geest DT Sleijfer NH Mulder EG de Vries 1989 Incidence and effects of herpes simplex virus infection after autologous bone marrow transplantation for solid tumours Neth J Med 34 126 131 2542817 1:STN:280:DyaL1M3mt1ersw%3D%3D (Pubitemid 19128214)
22. A Pohl-Koppe C Dahm M Elgas JE Kuhn RW Braun V ter Meulen 1992 The diagnostic significance of the polymerase chain reaction and isoelectric focusing in herpes simplex virus encephalitis J Med Virol 36 147 154 1316425 10.1002/jmv.1890360213 1:STN:280:DyaK383mtVWrug%3D%3D
23. R Saral RF Ambinder WH Burns CM Angelopulos DE Griffin PJ Burke PS Lietman 1983 Acyclovir prophylaxis against herpes simplex virus infection in patients with leukemia. A randomized, double-blind, placebo-controlled study Ann Intern Med 99 773 776 6359995 1:STN:280:DyaL2c%2FnvVSntA%3D%3D (Pubitemid 14248403)
24. R Saral WH Burns OL Laskin GW Santos PS Lietman 1981 Acyclovir prophylaxis of herpes-simplex-virus infections N Engl J Med 305 63 67 6264292 10.1056/NEJM198107093050202 1:STN:280:DyaL3M3itVOrug%3D%3D
25. ST Sonis 2004 Pathobiology of mucositis Semin Oncol Nurs 20 11 15 15038512 10.1053/j.soncn.2003.10.003 (Pubitemid 38609553)
26. ST Sonis LS Elting D Keefe DE Peterson M Schubert M Hauer-Jensen BN Bekele J Raber-Durlacher JP Donnelly EB Rubenstein 2004 Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients Cancer 100 1995 2025 15108222 10.1002/cncr.20162 (Pubitemid 38528741)
27. M Stockschlader P Kalhs S Peters W Zeller W Kruger H Kabisch K Lechner A Zander 1993 Intravenous pentoxifylline failed to prevent transplant-related toxicities in allogeneic bone marrow transplant recipients Bone Marrow Transplant 12 357 362 8275035 1:STN:280:DyaK2c7gtV2hsg%3D%3D (Pubitemid 23295519)
28. RH van der Jagt G Pari SA McDiarmid DM Boisvert LB Huebsch 1994 Effect of pentoxifylline on regimen related toxicity in patients undergoing allogeneic or autologous bone marrow transplantation Bone Marrow Transplant 13 203 207 8205090 (Pubitemid 24059146)
29. JC Wade B Newton N Flournoy JD Meyers 1984 Oral acyclovir for prevention of herpes simplex virus reactivation after marrow transplantation Ann Intern Med 100 823 828 6326632 1:STN:280:DyaL2c3gtFajtA%3D%3D (Pubitemid 14121591)
30. DI Warkentin JB Epstein LM Campbell JG Yip VC Cox A Ransier MJ Barnett F Marra 2002 Valacyclovir versus acyclovir for HSV prophylaxisin neutropenic patients Ann Pharmacother 36 1525 1531 12243600 10.1345/aph.1A434 1:CAS:528:DC%2BD38Xot1WhtLc%3D